Business mix
- The company operates through ADMA BioManufacturing and Plasma Collection Centers segments.
- It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S.
- pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities.
- The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers.
Current key questions
- Can the company's products, services, or pipeline expand adoption within biotechnology?
- How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
- Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
